The Japanese Journal of Urology
Online ISSN : 1884-7110
Print ISSN : 0021-5287
ISSN-L : 0021-5287
PD2-4 Survival Advantage of Temsirolimus Validates a Role for Mammalian Target of Rapamycin (mTOR) in the Biology of Advanced Renal Cell Carcinoma
Robert A. Figlin
Author information
JOURNAL FREE ACCESS

2008 Volume 99 Issue 2 Pages 134-

Details
Article 1st page
Content from these authors
© 2008 Japanese Urological Association
Previous article Next article
feedback
Top